Chemical compositions and uses thereof

US11473142B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11473142-B2
Application numberUS-202117476712-A
CountryUS
Kind codeB2
Filing dateSep 16, 2021
Priority dateFeb 12, 2018
Publication dateOct 18, 2022
Grant dateOct 18, 2022

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates to, among other things, probes, compositions, methods, and kits for simultaneous, multiplexed detection and quantification of protein and/or nucleic acid expression in a user-defined region of a tissue, user-defined cell, and/or user-defined subcellular structure within a cell that are adaptable for use with existing sequencing technologies.

First claim

Opening claim text (preview).

What is claimed is: 1. A method comprising: a) collecting a plurality of oligonucleotides from a first location of a tissue sample under conditions that release the plurality of oligonucleotides from the first location of the tissue sample; b) collecting a plurality of oligonucleotides from a second location of the tissue sample under conditions that release the plurality of oligonucleotides from the second location of the tissue sample; c) synthesizing a first plurality of DNA products by performing a synthesis reaction that uses the plurality of oligonucleotides collected in step (a) as templates and incorporates at least one nucleic acid sequence that identifies the first location of the tissue sample into each of the first plurality of DNA products; d) synthesizing a second plurality of DNA products by performing a synthesis reaction that uses the plurality of oligonucleotides collected in step (b) as templates and incorporates at least one nucleic acid sequence that identifies the second location of the tissue sample into each of the second plurality of DNA products; and e) identifying the first plurality of DNA products and the second plurality of DNA products synthesized in step (c) and step (d) by sequencing the first plurality of DNA products and the second plurality of DNA products, thereby spatially detecting the plurality of oligonucleotides collected from the first location of the tissue sample and the plurality of oligonucleotides collected from the second location of the tissue sample. 2. The method of claim 1 , wherein the tissue sample is immobilized onto a microscope slide. 3. The method of claim 2 , wherein the microscope slide comprises a plurality of primers immobilized on the microscope slide. 4. The method of claim 3 , wherein the plurality of primers is immobilized on the microscope slide at their 5′ ends. 5. The method of claim 4 , wherein each of step (c) and step (d) comprises performing a solid-phase amplification reaction, wherein the solid-phase amplification reaction is carried out on the microscope slide using the plurality of primers immobilized on the microscope slide. 6. The method of claim 1 , wherein the sequencing step is performed using a next generation sequencing reaction. 7. The method of claim 1 , further comprises amplifying a library using the first plurality of DNA products and the second plurality of DNA products as templates. 8. The method of claim 1 , wherein the at least one nucleic acid sequence that identifies the first location of the tissue sample comprise at least one unique molecular identifier. 9. The method of claim 1 , wherein the at least one nucleic acid sequence that identifies the second location of the tissue sample comprise at least one unique molecular identifier. 10. The method of claim 1 , wherein the first plurality of DNA products further comprises at least one amplification primer binding site. 11. The method of claim 1 , wherein the second plurality of DNA products further comprises at least one amplification primer binding site. 12. The method of claim 1 , wherein steps (a) and (b) are performed simultaneously. 13. The method of claim 1 , wherein steps (c) and (d) are performed simultaneously.

Assignees

Inventors

Classifications

  • C12Q1/6869Primary

    Methods for sequencing · CPC title

  • C12Q1/6804Primary

    Nucleic acid analysis using immunogens (immunoassay G01N33/53) · CPC title

  • In situ hybridisation · CPC title

  • Polymerase chain reaction [PCR] · CPC title

  • Allele-specific amplification · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11473142B2 cover?
The present invention relates to, among other things, probes, compositions, methods, and kits for simultaneous, multiplexed detection and quantification of protein and/or nucleic acid expression in a user-defined region of a tissue, user-defined cell, and/or user-defined subcellular structure within a cell that are adaptable for use with existing sequencing technologies.
Who is the assignee on this patent?
Nanostring Technologies Inc
What technology area does this patent fall under?
Primary CPC classification C12Q1/6869. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Oct 18 2022 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 12 related publications on this page (citations in our corpus or others sharing the same primary CPC).